Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexamethasone for prevention of nausea and vomiting after strabismus surgery
IRCT20180416039326N12Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Severity of nausea and vomiting. Started Apr 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20180416039326N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N12.